z-logo
open-access-imgOpen Access
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6
Author(s) -
Ran Li,
Zhengqin Ye,
Dunmin She,
Ping Fang,
Guannan Zong,
Kerong Hu,
Dehong Kong,
Wei Xu,
Ling Li,
Yun Zhou,
Keqin Zhang,
Ying Xue
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s384884
Subject(s) - steatosis , semaglutide , fatty liver , medicine , endocrinology , biology , diabetes mellitus , type 2 diabetes , disease , liraglutide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom